IRVINE, CALIF., January 20, 2025 – Our discovery chemistry team has been awarded the prestigious 2024 Best CRO Award by Daewoong Pharmaceutical. Selected from among numerous Contract Research Organization (CRO) partners, this recognition highlights BioDuro's exceptional contributions to advancing multiple challenging projects over the past year. The award was presented on behalf of Daewoong by Chemone, one of our valued partners, underscoring the collaborative efforts that have driven these achievements.
Over the past year, BioDuro and Daewoong Pharmaceutical forged a strong partnership, making remarkable progress on several complex drug discovery projects. With the support of trusted collaborators like Chemone, both companies are committed to strengthening their collaboration, sharing a vision of advancing the discovery and development of innovative, life-changing therapies.
As a leading global CRDMO (Contract Research, Development, and Manufacturing Organization), we offer comprehensive services spanning early drug discovery to commercial manufacturing. The discovery chemistry team, comprising over 1,100 scientists across 5 campuses with extensive expertise in small molecules, peptides and antibody-drug conjugates.